Original Research

Published on 10 Oct 2024

Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction

in Cancer Immunity and Immunotherapy

Jinyu Liu
Mengli Chen
Shu Li
Le Cai
Liang Ma
Qiuliang Yang
Xiaoxuan Zhang
Nan Bai
Xiaodong Wu
Zhihui Tang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1458488

782 views

Review

Published on 10 Oct 2024

Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC

in Cancer Immunity and Immunotherapy

Muhammad Naveed Khan
Binli Mao
Juan Hu
Mengjia Shi
Shunyao Wang
Adeel Ur Rehman
Xiaosong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472430

1,358 views

Review

Published on 10 Oct 2024

Bispecific antibody targets and therapies in multiple myeloma

in Cancer Immunity and Immunotherapy

Matthew Rees
Nadine Abdallah
Binoy Yohannan
Wilson I. Gonsalves

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424925

1,614 views

Case Report

Published on 10 Oct 2024

Case report: A case of sintilimab-induced recurrent diabetic ketoacidosis and thyroid dysfunction in a patient with advanced cervical carcinoma

in Cancer Immunity and Immunotherapy

Chunliang Wang
Ye Cai
Pei Feng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1405856

643 views

Original Research

Published on 10 Oct 2024

Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention

in Cancer Immunity and Immunotherapy

Cheryl M. Cameron
Vineet Raghu
Brian Richardson
Leah L. Zagore
Banumathi Tamilselvan
Jackelyn Golden
Michael Cartwright
Robert E. Schoen
Olivera J. Finn
Panayiotis V. Benos

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437391

1,001 views

Original Research

Published on 10 Oct 2024

Understanding bladder cancer risk: Mendelian randomization analysis of immune cell and inflammatory factor influence

in Cancer Immunity and Immunotherapy

Hiocheng Un
Wumier Wusimanjiang
Wenhao Zhan
Xinxin Zhang
Minghao Li
Jiahao Lei
Renxuan Lin
Yuliang Zhang
Junxing Chen
Zongren Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1460275

882 views

Review

Published on 10 Oct 2024

Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies

in Cancer Immunity and Immunotherapy

Chin-King Looi
Ee-Mun Loo
Heng-Chee Lim
Yik-Ling Chew
Kok-Yong Chin
Shiau-Chuen Cheah
Bey Hing Goh
Chun-Wai Mai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1484535

1,140 views

Original Research

Published on 10 Oct 2024

Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells

in Cancer Immunity and Immunotherapy

Sergey Sennikov
Marina Volynets
Saleh Alrhmoun
Roman Perik-Zavodskii
Olga Perik-Zavodskaia
Marina Fisher
Julia Lopatnikova
Julia Shevchenko
Kirill Nazarov
Julia Philippova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470130

872 views

Review

Published on 09 Oct 2024

Targeting STING signaling for the optimal cancer immunotherapy

in Cancer Immunity and Immunotherapy

Yan Xu
Ying Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482738

1,190 views

Original Research

Published on 09 Oct 2024

Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma

in Cancer Immunity and Immunotherapy

Binbin Zou
Mingtai Li
Jiachen Zhang
Yingzhen Gao
Xiaoya Huo
Jinhu Li
Yimin Fan
Yanlin Guo
Xiaodong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467858

897 views

Original Research

Published on 09 Oct 2024

Integrated analysis and experiments uncover the function of disulfidptosis in predicting immunotherapy effectiveness and delineating immune landscapes in uterine corpus endometrial carcinoma

in Cancer Immunity and Immunotherapy

Lei Han
Yilin Li
Yanjie Yu
Guo Liu
Xiangqian Gao
Fei Wang
Weiwei Chen
Huishu Xu
Baolin Zhang
Yingjiang Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454730

828 views

Original Research

Published on 09 Oct 2024

Global research trends and hotspots in metabolomics of osteosarcoma: a decade-spanning bibliometric and visualized analysis

in Cancer Immunity and Immunotherapy

Jun-Bo Tu
Tao Liu
Jun-Feng Li
Jian Long
Xiu Wang
Wen-Cai Liu
Xing-Hua Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463078

697 views

Study Protocol

Published on 09 Oct 2024

SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study

in Cancer Immunity and Immunotherapy

Pei Zhang
Xiaofen Li
Xin Wang
Yu Yang
Jianfei Wang
Dan Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450533

846 views

Review

Published on 09 Oct 2024

Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy

in Cancer Immunity and Immunotherapy

Yukun Chen
Zhenzhi Wang
Chi Zhang
Yisa Su
Tian Zhou
Kaiwen Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470071

716 views

Original Research

Published on 09 Oct 2024

Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach

in Cancer Immunity and Immunotherapy

Long Hai
Xiao-Yang Bai
Xia Luo
Shuai-Wei Liu
Zi-Min Ma
Li-Na Ma
Xiang-Chun Ding

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444091

858 views

Original Research

Published on 09 Oct 2024

Multi-omics analyses were combined to construct ubiquitination-related features in colon adenocarcinoma and identify ASNS as a novel biomarker

in Cancer Immunity and Immunotherapy

Zhaohui Wang
Wenbing Zhang
Xin Yin
Qinqing Wu
Yongwei Zhang
Yeben Qian
Qian Bao
Fubao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466286

1,004 views

Navigation group

Articles

Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction

Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC

Bispecific antibody targets and therapies in multiple myeloma

Case report: A case of sintilimab-induced recurrent diabetic ketoacidosis and thyroid dysfunction in a patient with advanced cervical carcinoma

Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention

Understanding bladder cancer risk: Mendelian randomization analysis of immune cell and inflammatory factor influence

Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies

Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells

Targeting STING signaling for the optimal cancer immunotherapy

Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma

Integrated analysis and experiments uncover the function of disulfidptosis in predicting immunotherapy effectiveness and delineating immune landscapes in uterine corpus endometrial carcinoma

Global research trends and hotspots in metabolomics of osteosarcoma: a decade-spanning bibliometric and visualized analysis

SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study

Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy

Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach

Multi-omics analyses were combined to construct ubiquitination-related features in colon adenocarcinoma and identify ASNS as a novel biomarker